- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Novavax (NVAX) is a leading biotechnology business based in the US. It opened the day at $9.90 after a previous close of $9.75. During the day the price has varied from a low of $9.73 to a high of $10.48. The latest price was $10.25 (25 minute delay). Novavax is listed on the NASDAQ and employs 1,543 staff. All prices are listed in US Dollars.
Our top picks for where to buy Novavax stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Novavax stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NVAX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Novavax stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Novavax stock price (NASDAQ: NVAX)
Use our graph to track the performance of NVAX stocks over time.Novavax shares at a glance
Information last updated 2024-10-15.
| Open | $12.67 |
|---|---|
| High | $12.86 |
| Low | $12.38 |
| Close | $12.81 |
| Previous close | $12.62 |
| Change | $0.19 |
| Change % | 1.5055% |
| Volume | 1,651,622 |
Information last updated 2024-10-24.
| 52-week range | $3.53 - $23.86 |
|---|---|
| 50-day moving average | $12.28 |
| 200-day moving average | $9.64 |
| Wall St. target price | $19.60 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.60 |
Is it a good time to buy Novavax stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Novavax price performance over time
Historical closes compared with the close of $10.25 from 2024-10-25
| 1 week (2024-10-22) | 1.28% |
|---|---|
| 1 month (2024-09-27) | -22.93% |
| 3 months (2024-07-29) | -37.58% |
| 6 months (2024-04-29) | 138.93% |
| 1 year (2023-10-27) | 61.42% |
|---|---|
| 2 years (2022-10-28) | -55.47% |
| 3 years (2021-10-29) | 148.83 |
| 5 years (2019-10-29) | 127.78% |
Novavax financials
| Revenue TTM | $987.7 million |
|---|---|
| Operating margin TTM | 39.01% |
| Gross profit TTM | $-156,045,000 |
| Return on assets TTM | -10.21% |
| Return on equity TTM | -898.2% |
| Profit margin | -29.8% |
| Book value | $-2.70 |
| Market Capitalization | $1.6 billion |
TTM: trailing 12 months
Novavax share dividends
We're not expecting Novavax to pay a dividend over the next 12 months.
Have Novavax's shares ever split?
Novavax's shares were split on a 1:20 basis on 9 May 2019 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novavax shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Novavax shares which in turn could have impacted Novavax's share price.
Novavax share price volatility
Over the last 12 months, Novavax's shares have ranged in value from as little as $3.5324 up to $23.8599. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novavax's is 2.033. This would suggest that Novavax's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Novavax overview
Novavax, Inc. , a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc.
Frequently asked questions
What percentage of Novavax is owned by insiders or institutions?Currently 4.38% of Novavax shares are held by insiders and 54.155% by institutions. How many people work for Novavax?
Latest data suggests 1,543 work at Novavax. When does the fiscal year end for Novavax?
Novavax's fiscal year ends in December. Where is Novavax based?
Novavax's address is: 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 What is Novavax's ISIN number?
Novavax's international securities identification number is: US6700024010 What is Novavax's CUSIP number?
Novavax's Committee on Uniform Securities Identification Procedures number is: 670002401
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question